ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Cosmos Pharmaceutical Corporation (PK)

Cosmos Pharmaceutical Corporation (PK) (CSMYF)

49.22
0.00
(0.00%)
Closed 09 December 8:00AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
49.22
Bid
45.56
Offer
54.01
Volume
-
0.00 Day's Range 0.00
39.215 52 Week Range 51.06
Market Cap
Previous Close
49.22
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
67
Shares Outstanding
39,598,915
Dividend Yield
-
PE Ratio
0.08
Earnings Per Share (EPS)
617.54
Revenue
964.99B
Net Profit
24.45B

About Cosmos Pharmaceutical Corporation (PK)

Sector
Drug & Proprietary Stores
Industry
Retail Trade (svc)
Headquarters
Fukuoka, Fukuoka, Jpn
Founded
1991
Cosmos Pharmaceutical Corporation (PK) is listed in the Drug & Proprietary Stores sector of the OTCMarkets with ticker CSMYF. The last closing price for Cosmos Pharmaceutical (PK) was US$49.22. Over the last year, Cosmos Pharmaceutical (PK) shares have traded in a share price range of US$ 39.215 to US$ 51.06.

Cosmos Pharmaceutical (PK) currently has 39,598,915 shares in issue. The market capitalisation of Cosmos Pharmaceutical (PK) is US$1.95 billion. Cosmos Pharmaceutical (PK) has a price to earnings ratio (PE ratio) of 0.08.

CSMYF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10049.2249.2249.2210049.22CS
40049.2249.2249.2210049.22CS
129.9225.241730279939.351.0639.36750.14CS
2610.00525.513196480939.21551.0639.21510042.885CS
520.060.12205044751849.1651.0639.2156742.885CS
156-22.84835-31.703722924172.0683578.5378239.2156352.267505CS
260-29.31782-37.329556639178.5378285.1683539.2158968.57825292CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
US$ 0.0381
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0225
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0381
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0225
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0381
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0225
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0

Discussion

View Full Feed
exwannabe exwannabe 1 minute ago
Progression-free Survival (PFS) was an INITIAL endpoint ...
PFS was the primary endpoint and used in the 2015 efficacy IA. Had it been a success they would have submitted for approval based on it many years ago. But the trial failed to establish the endpoint and the reason does not matter.
NWBO
LVerstee LVerstee 1 minute ago
I thought you were https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175497600 not going to answer him?

Yes, they can all go to hell, the employees in India. I should sue them, for not paying me.
ITUP
SlamDunk89 SlamDunk89 1 minute ago
Wayyyyyyy oversold.
RONN
Real McCoy Real McCoy 2 minutes ago
They reported every aspect of a lengthy restructuring attempt and ultimate liquidation though.
biocqr biocqr 3 minutes ago
Was up 20% then down 10% now no change...sheesh.
ENTA
rakp rakp 3 minutes ago
What's this company all about?
INFINITI INFINITI 5 minutes ago
Looking good for a rebound here $$$$$$$
RIME
sab63090 sab63090 6 minutes ago
Guzzi62

Thanks much, this was a very honest review in my opinion:

This is a major precipitous step because whatever funny business people may accuse a company of doing - and there have been a lot of such accusations here - an MAA brings everything under the spotlight.
AVXL
Energy Manager Energy Manager 6 minutes ago
A little food for thought from the DEA...

https://www.justthinktwice.gov/sites/default/files/2022-12/Impaired%20Driving%20Fact%20Card%20Web.pdf?utm_medium=email&utm_source=govdelivery
LCTC
Energy Manager Energy Manager 6 minutes ago
A little food for thought from the DEA...

https://www.justthinktwice.gov/sites/default/files/2022-12/Impaired%20Driving%20Fact%20Card%20Web.pdf?utm_medium=email&utm_source=govdelivery
LCTC
floblu14 floblu14 7 minutes ago
Monday, December 09, 2024 6:38:42 AM

Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)
Dec 09, 2024

Observed an antiviral effect for the p
ENTA
ksquared ksquared 7 minutes ago
Adam Schiff to Take Office Monday, Not in January, After Newsom Makes Power Play to Help California
JOEL B. POLLAK 8 Dec 2024 0:34

Representative Adam Schiff (D-CA) will become Senator Adam Schiff (D-CA) on Monday, December 9, after current Sen. Laphonza Butler (D-CA) resigne
FooBarAndGrill FooBarAndGrill 8 minutes ago
Sector is popping. $QBTS $RGTI $QUBT
QBTS RGTI
Risk vs Reward Risk vs Reward 9 minutes ago
Sells are 2:1 this am so far 
KULR
Debunkinator Debunkinator 10 minutes ago
$ASII--Let's have a barn burner of a week. 🚀 Past Due
ASII
Risk vs Reward Risk vs Reward 10 minutes ago
Somethings coming this week.... would be good timing after the pps cool down 
KULR
Reefrad Reefrad 10 minutes ago
I'm surprised you no longer bring up your "GBM" diagnosis. I guess you finally realized it if didn't really work so well with your agenda. Smart move. Then again, based on your incessant postings I would guess you might actually have had a frontal lobe or two resected. 
NWBO
floblu14 floblu14 11 minutes ago
Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)
Dec 09, 2024

Observed an antiviral effect for the primary and secondary virology endpoints in the overa
ENTA
biocqr biocqr 12 minutes ago
News out ENTA up 20%.

https://ir.enanta.com/news-releases/news-release-details/enanta-pharmaceuticals-announces-positive-topline-results-first

Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the
ENTA
Moonboy1 Moonboy1 14 minutes ago
What is this up so much? I don't see any news
GXAI
Streett Streett 15 minutes ago
Who owns the patent?  What we know for sure is that in the deal, if I have this right, HUMBL Pro is what remains in the HUMBL shell.  Everything else went to WSCG... correct?  The new company is bringing in a lot of product and if the SMX deal goes through, they will bring their own set of patents t
SMX
MasterBlastr MasterBlastr 16 minutes ago
I love Biden. He may not be a master politician, but he is a master of governing. He is setting things to run on autopilot while the Circus is in town.
Moonboy1 Moonboy1 17 minutes ago
All I know is I have shares and living it this morning
GXAI
dennisdave dennisdave 17 minutes ago
No one said they would look different "in the fall of this year". Innes said the company would like very different by THE END of this year.

Powers said this at last ASM:

It’s been longer than it was supposed to be (not shit), but all in all, I have to say, we’ve made, w
NWBO
TrendTrade2016 TrendTrade2016 20 minutes ago
ARE YOU STILL PRETENDING YOU ARE A WOMAN OR HAVE YOU COME OUT OF THE CLOSET MAGGOT
GVSI

Your Recent History

Delayed Upgrade Clock